Dianthus Therapeutics vs Korsana Biosciences
DNTH and KRSA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DNTH and KRSA compare
Dianthus Therapeutics is the larger company, worth 3.6 times as much as Korsana Biosciences ($5.1B against $1.4B).
Korsana Biosciences scores higher on the StockData Score (8 against 7 for Dianthus Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DNTH | KRSA |
|---|---|---|
| Size and price | ||
| Market cap | $5.1B | $1.4B |
| Share price | $91.81 | $31.65 |
| Change, 1 year | 137% | 218% |
| Change, 5 years | −14.2% | −90.3% |
| Beta (5Y) | 1.44 | 1.41 |
| Employees | 92 | 1 |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 1 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/B | 4.1× | 3.7× (better) |
| Growth | ||
| Revenue growth, 5Y average | – | −2.0% |
| Profitability | ||
| Return on equity | −22.6% (better) | −31.8% |
| Return on invested capital | −22.2% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 30.02 (better) | 10.42 |
| Altman Z-score | 88.13 (better) | 19.65 |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | −0.01% | – |
| Shareholder yield | −0.01% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 118% | 1.6% |
| Held by insiders | 9.1% | 46.5% |
| Insider net buying, 12 months | −$75.1M | – |
| Short interest, % of float | 18.2% | 0.69% |
Go deeper
- DNTH stock overview
- DNTH income statement
- DNTH valuation and score
- KRSA stock overview
- KRSA income statement
- KRSA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.